# Effects of the Bifidobacterium Longum BL21 on BMI, Metabolic Indicators, and Gut Microbiota in Overweight/Obese Adults

> **NCT06140641** · NA · UNKNOWN · sponsor: **Qilu Hospital of Shandong University** · enrollment: 72 (estimated)

## Conditions studied

- Overweight/Obese Adults

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotics

## Key facts

- **NCT ID:** NCT06140641
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-11-10
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-08-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2023-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06140641

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06140641, "Effects of the Bifidobacterium Longum BL21 on BMI, Metabolic Indicators, and Gut Microbiota in Overweight/Obese Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06140641. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*